News

News
Partner news

Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease

Read full story
Press release

Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration

Read full story
Press release

Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal

Read full story
JNJ Press releases

Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal

Read full story
Other news

Aetion adds strategic investment from Johnson & Johnson Innovation - JJDC, Inc., EDBI, Greenspring Associates to expand RWE offerings

Read full story
Partner news

GI Windows Raises $16.4M in Series A-1 Financing

Read full story
Partner news

Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases

Read full story
Partner news

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

Read full story
Partner news

Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors

Read full story
Partner news

ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate

Read full story